Acorda Therapeutics Probability of Future Stock Price Finishing Over 16.2
| ACORDelisted Stock | USD 16.20 0.40 2.41% |
Acorda |
Acorda Therapeutics Target Price Odds to finish over 16.2
The tendency of Acorda Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 16.20 | 90 days | 16.20 | about 8.97 |
Based on a normal probability distribution, the odds of Acorda Therapeutics to move above the current price in 90 days from now is about 8.97 (This Acorda Therapeutics probability density function shows the probability of Acorda Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.28 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Acorda Therapeutics will likely underperform. Additionally Acorda Therapeutics has an alpha of 0.9555, implying that it can generate a 0.96 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Acorda Therapeutics Price Density |
| Price |
Predictive Modules for Acorda Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Acorda Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Acorda Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Acorda Therapeutics is not an exception. The market had few large corrections towards the Acorda Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Acorda Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Acorda Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.96 | |
β | Beta against Dow Jones | 1.28 | |
σ | Overall volatility | 2.54 | |
Ir | Information ratio | 0.09 |
Acorda Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Acorda Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Acorda Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Acorda Therapeutics is not yet fully synchronised with the market data | |
| Acorda Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 117.63 M. Net Loss for the year was (252.85 M) with profit before overhead, payroll, taxes, and interest of 82.43 M. | |
| Acorda Therapeutics currently holds about 20.7 M in cash with (13.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.85. | |
| Latest headline from patch.com: A Letter To The Undocumented In Sonoma County |
Acorda Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Acorda Stock often depends not only on the future outlook of the current and potential Acorda Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Acorda Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.2 M | |
| Cash And Short Term Investments | 30.4 M |
Acorda Therapeutics Technical Analysis
Acorda Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Acorda Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Acorda Therapeutics. In general, you should focus on analyzing Acorda Stock price patterns and their correlations with different microeconomic environments and drivers.
Acorda Therapeutics Predictive Forecast Models
Acorda Therapeutics' time-series forecasting models is one of many Acorda Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Acorda Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Acorda Therapeutics
Checking the ongoing alerts about Acorda Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Acorda Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Acorda Therapeutics is not yet fully synchronised with the market data | |
| Acorda Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 117.63 M. Net Loss for the year was (252.85 M) with profit before overhead, payroll, taxes, and interest of 82.43 M. | |
| Acorda Therapeutics currently holds about 20.7 M in cash with (13.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.85. | |
| Latest headline from patch.com: A Letter To The Undocumented In Sonoma County |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in Acorda Stock
If you are still planning to invest in Acorda Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acorda Therapeutics' history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |